March 2019: Biocompatibility confirmed

Updated: Jan 8, 2020

The OptiShunt has successfully passed biocompatibility testing including animal implantation studies by Nelson Labs, Europe. This is the last development milestone we required before proceeding with clinical trials.


Glaucoma remains a leading cause of blindness worldwide, affecting over 70 million people

Contact

Dr Daemon McClunan, Founder
email: daemon@liqidmedical.com

mobile: +27 (0)84 604 7600

location: Cape Town, South Africa

© 2017 Copyright reserved. Online Solutions by CassandraGroenewald.com